PHC Holdings Corp 6523
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 6523 is a good fit for your portfolio.
News
-
Epredia and NovaScan Announce Intent to Enter U.S. Distribution Agreement for MarginScan™ Device for Non-Melanoma Skin Cancer Detection
-
Eversense® CGM System Receives iCGM Designation by the US FDA
-
SAVINGS OFFER FOR THE EVERSENSE E3 CGM EXTENDED TO COVER UNLIMITED NUMBER OF SYSTEMS
-
MEDICARE COVERAGE SIGNIFICANTLY EXPANDED FOR THE EVERSENSE E3 CGM SYSTEM
-
Medicare Coverage Significantly Expanded for the Eversense E3 CGM System
-
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
-
PHC Holdings Corporation and Senseonics Announce Appointment of Brian Hansen as President of CGM at Ascensia Diabetes Care
Trading Information
- Previous Close Price
- JPY 1,159.00
- Day Range
- JPY 1,150.00–1,167.00
- 52-Week Range
- JPY 1,081.00–1,650.00
- Bid/Ask
- JPY 1,161.00 / JPY 1,164.00
- Market Cap
- JPY 146.45 Bil
- Volume/Avg
- 197,300 / 496,693
Key Statistics
- Price/Earnings (Normalized)
- 6.02
- Price/Sales
- 0.42
- Dividend Yield (Trailing)
- 6.21%
- Dividend Yield (Forward)
- 6.21%
- Total Yield
- 6.21%
Company Profile
PHC Holdings Corp is engaged in the development, manufacture and sale of healthcare devices and services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 11,897
- Website
- https://www.phchd.com
Comparables
Valuation
|
Metric
|
6523
|
7979
|
9341
|
|---|---|---|---|
Price/Earnings (Normalized) | 6.02 | 12.79 | 10.84 |
Price/Book Value | 1.17 | 1.40 | 4.48 |
Price/Sales | 0.42 | 1.64 | 2.87 |
Price/Cash Flow | 3.84 | 13.62 | 12.32 |
Price/Earnings
6523
7979
9341
Financial Strength
|
Metric
|
6523
|
7979
|
9341
|
|---|---|---|---|
Quick Ratio | 0.82 | 2.69 | 4.27 |
Current Ratio | 1.31 | 5.05 | 4.34 |
Interest Coverage | −0.43 | 180.72 | 4,212.64 |
Quick Ratio
6523
7979
9341
Profitability
|
Metric
|
6523
|
7979
|
9341
|
|---|---|---|---|
Return on Assets (Normalized) | 1.01% | 9.57% | 37.98% |
Return on Equity (Normalized) | 4.11% | 11.56% | 49.46% |
Return on Invested Capital (Normalized) | 4.17% | 10.88% | 48.75% |
Return on Assets
6523
7979
9341
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Vfldtky | Zyhqt | $184.2 Bil | |
SYK
| Stryker Corp | Dgsbfmrtzf | Tndr | $125.1 Bil | |
MDT
| Medtronic PLC | Cqgbxpqy | Csbtfv | $108.5 Bil | |
BSX
| Boston Scientific Corp | Zgjtzbpy | Sdxxcn | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Qwfczzbclw | Tfkxvvx | $51.4 Bil | |
DXCM
| DexCom Inc | Hnnctlrnfv | Wwcrv | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Mddhvlhmtx | Hmr | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Qvwstnfy | Pgjfv | $24.4 Bil | |
ALGN
| Align Technology Inc | Gwmdbqkf | Wcqkyh | $21.7 Bil | |
PODD
| Insulet Corp | Rjmwqwtjp | Wcrdhn | $12.2 Bil |